Venus Concept Accounts Receivables 2011-2026 | VERO

Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.

Examples of accounts receivable

Customers have not paid invoices for delivered products
An advance has been paid to a supplier, but goods have not yet been received
Employees have not reported on accountable amounts
The government must refund tax overpayments
Outstanding loans issued

Importance of accounts receivable in company analysis

Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment.
Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages.
Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)

Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)

If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.

Annual Accounts Receivables Venus Concept

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
26 M	38.3 M	54 M	70.6 M	70.2 M	89 M	6.57 M	3.86 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
89 M	3.86 M	44.8 M

Quarterly Accounts Receivables Venus Concept

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
24.4 M	24.1 M	23.8 M	26 M	28.5 M	32.4 M	34.9 M	38.3 M	41.9 M	47.1 M	51.5 M	54 M	60.2 M	69.2 M	72.7 M	70.6 M	67.2 M	68.4 M	66.9 M	70.2 M	70.2 M	70.2 M	70.2 M	89 M	89 M	89 M	89 M	69 M	6.57 M	6.57 M	6.57 M	3.86 M	3.86 M	3.86 M	3.86 M	2.48 M	2.48 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
89 M	2.48 M	44.5 M

Accounts Receivables of other stocks in the Medical devices industry

Issuer	Accounts Receivables	Price	% 24h	Market Cap	Country
Aethlon Medical AEMD	128 K	$ 2.19	2.34 %	$ 3.42 M	USA
AdaptHealth Corp. AHCO	371 M	$ 10.76	3.26 %	$ 1.45 B	USA
Allied Healthcare Products AHPI	2.37 M	-	3.58 %	$ 2.21 M	USA
Acutus Medical AFIB	11.4 M	-	-26.83 %	$ 2.62 M	USA
Butterfly Network BFLY	20.8 M	$ 4.16	6.39 %	$ 881 M	USA
Alphatec Holdings ATEC	97.3 M	$ 12.79	1.51 %	$ 1.92 B	USA
Aziyo Biologics AZYO	1.73 M	-	1.37 %	$ 20.5 M	USA
Avinger AVGR	1.01 M	-	-20.74 %	$ 369 K	USA
BIOLASE BIOL	5.48 M	-	-13.19 %	$ 166 K	USA
Cognyte Software Ltd. CGNT	175 M	$ 8.41	0.36 %	$ 604 M	Israel
CONMED Corporation CNMD	248 M	$ 36.62	-2.11 %	$ 1.14 B	USA
Conformis CFMS	9.77 M	-	-	$ 16.4 M	USA
Cytosorbents Corporation CTSO	7.32 M	$ 0.69	6.85 %	$ 37.6 M	USA
Apollo Endosurgery APEN	15 M	-	-	$ 475 M	USA
EDAP TMS S.A. EDAP	18.6 M	$ 4.16	4.95 %	$ 155 M	France
Cutera CUTR	43.1 M	-	-10.19 %	$ 1.99 M	USA
Establishment Labs Holdings ESTA	77.5 M	$ 65.06	2.49 %	$ 1.93 B	Costa-rica
Dynatronics Corporation DYNT	2.8 M	-	14.99 %	$ 929 K	USA
ClearPoint Neuro CLPT	4.71 M	$ 11.2	1.5 %	$ 303 M	USA
Axonics Modulation Technologies AXNX	44.8 M	-	-	$ 3.31 B	USA
Helius Medical Technologies HSDT	117 K	$ 2.19	-	$ 1.33 M	USA
LivaNova PLC LIVN	216 M	$ 62.11	1.1 %	$ 3.39 B	Britain
GBS GBS	595 K	-	-0.57 %	$ 7.12 M	USA
InMode Ltd. INMD	10.5 M	$ 13.67	1.79 %	$ 884 M	Israel
Abbott Laboratories ABT	7.93 B	$ 111.4	1.32 %	$ 194 B	USA
IRIDEX Corporation IRIX	6.73 M	$ 1.34	0.77 %	$ 21.6 M	USA
Delcath Systems DCTH	11.7 M	$ 9.87	0.56 %	$ 354 M	USA
Bio-Rad Laboratories BIO	452 M	$ 266.93	2.18 %	$ 7.53 B	USA
Integra LifeSciences Holdings Corporation IART	272 M	$ 9.28	3.0 %	$ 715 M	USA
AxoGen AXGN	26.2 M	$ 33.06	0.68 %	$ 1.52 B	USA
Align Technology ALGN	996 M	$ 177.13	4.53 %	$ 13.3 B	USA
Bruker Corporation BRKR	566 M	$ 33.64	2.69 %	$ 5.01 K	USA
BioSig Technologies BSGM	109 K	-	37.08 %	$ 85.7 M	USA
Apyx Medical Corporation APYX	16.8 M	$ 3.83	4.36 %	$ 157 M	USA
OrthoPediatrics Corp. KIDS	53.8 M	$ 17.3	1.08 %	$ 406 M	USA
Integer Holdings Corporation ITGR	346 M	$ 86.69	3.12 %	$ 3.01 B	USA
Invacare Corporation IVC	88 M	-	-	$ 24.7 M	USA